Holen Sie sich die Stockscreener-App
101.03
2.13%
-2.6304
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CROX?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$103.66
Offen:
$101.7
24-Stunden-Volumen:
78,696
Relative Volume:
0.04
Marktkapitalisierung:
$5.62B
Einnahmen:
$4.07B
Nettoeinkommen (Verlust:
$834.75M
KGV:
7.3263
EPS:
13.79
Netto-Cashflow:
$940.16M
1W Leistung:
-0.01%
1M Leistung:
-15.64%
6M Leistung:
-9.19%
1J Leistung:
-36.05%
1-Tages-Spanne:
$100.92
$102.42
1-Wochen-Bereich:
$101.20
$107.08
52-Wochen-Spanne:
$86.11
$165.32
Crocs Inc Stock (CROX) Company Profile
Firmenname
Crocs Inc
Sektor
Branche
Telefon
(303) 848-7000
Adresse
500 ELDORADO BOULEVARD, BROOMFIELD
Vergleichen Sie CROX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CROX
Crocs Inc
|
101.09 | 5.62B | 4.07B | 834.75M | 940.16M | 13.79 |
|
NKE
Nike Inc
|
62.39 | 92.50B | 47.82B | 4.51B | 5.31B | 3.01 |
|
ONON
On Holding Ag
|
54.71 | 18.57B | 2.64B | 275.92M | 506.27M | 0.8314 |
|
DECK
Deckers Outdoor Corp
|
105.59 | 16.19B | 4.66B | 875.41M | 856.46M | 5.6867 |
|
BIRK
Birkenstock Holding Plc
|
52.43 | 10.16B | 2.02B | 237.34M | 421.38M | 1.2687 |
|
SKX
Skechers U S A Inc
|
62.66 | 9.30B | 9.13B | 635.29M | 112.55M | 4.16 |
Crocs Inc Stock (CROX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-12 | Hochstufung | Loop Capital | Hold → Buy |
| 2024-11-22 | Eingeleitet | Needham | Buy |
| 2024-11-07 | Herabstufung | Loop Capital | Buy → Hold |
| 2024-10-30 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2024-10-30 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2024-10-09 | Eingeleitet | Guggenheim | Buy |
| 2024-08-23 | Fortgesetzt | Piper Sandler | Overweight |
| 2024-08-02 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2024-05-08 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2024-04-01 | Eingeleitet | Barclays | Overweight |
| 2024-02-07 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2023-12-12 | Eingeleitet | BofA Securities | Buy |
| 2023-11-28 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-10-20 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2023-09-07 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2023-07-28 | Hochstufung | Stifel | Hold → Buy |
| 2023-06-14 | Eingeleitet | Raymond James | Mkt Perform |
| 2023-03-30 | Eingeleitet | B. Riley Securities | Buy |
| 2022-09-21 | Eingeleitet | Exane BNP Paribas | Neutral |
| 2022-07-26 | Fortgesetzt | Piper Sandler | Overweight |
| 2022-07-05 | Hochstufung | Loop Capital | Hold → Buy |
| 2022-04-29 | Eingeleitet | Wedbush | Outperform |
| 2022-04-04 | Herabstufung | Loop Capital | Buy → Hold |
| 2022-01-18 | Eingeleitet | Seaport Research Partners | Neutral |
| 2021-09-15 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2021-07-23 | Bestätigt | B. Riley Securities | Buy |
| 2021-07-23 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2021-04-28 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2021-02-19 | Bestätigt | Pivotal Research Group | Buy |
| 2021-01-13 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2021-01-12 | Bestätigt | Pivotal Research Group | Buy |
| 2020-10-28 | Bestätigt | B. Riley Securities | Buy |
| 2020-10-28 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2020-10-20 | Bestätigt | Pivotal Research Group | Buy |
| 2020-10-14 | Bestätigt | B. Riley Securities | Buy |
| 2020-10-14 | Bestätigt | Piper Sandler | Overweight |
| 2020-08-25 | Hochstufung | B. Riley FBR | Neutral → Buy |
| 2020-07-31 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2020-07-22 | Eingeleitet | UBS | Neutral |
| 2020-07-17 | Herabstufung | CL King | Buy → Neutral |
| 2020-06-30 | Hochstufung | Loop Capital | Hold → Buy |
| 2020-06-08 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2020-05-22 | Eingeleitet | B. Riley FBR | Neutral |
| 2020-04-21 | Bestätigt | Pivotal Research Group | Buy |
| 2020-03-31 | Eingeleitet | Loop Capital | Hold |
| 2020-03-31 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2020-02-24 | Bestätigt | Pivotal Research Group | Buy |
| 2020-01-15 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2020-01-15 | Bestätigt | Pivotal Research Group | Buy |
| 2019-10-31 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2019-09-17 | Bestätigt | Piper Jaffray | Overweight |
Alle ansehen
Crocs Inc Aktie (CROX) Neueste Nachrichten
Davis Investment Partners LLC Has $531,000 Stock Holdings in Crocs, Inc. (NASDAQ:CROX) - MarketBeat
656 Shares in Crocs, Inc. (NASDAQ:CROX) Purchased by NBC Securities Inc. - Defense World
Crocs Confirms Key Decisions at Annual Meeting - TipRanks
GAMMA Investing LLC Buys 143,690 Shares of Crocs, Inc. (NASDAQ:CROX) - MarketBeat
CMC Financial Group Makes New $391,000 Investment in Crocs, Inc. (NASDAQ:CROX) - MarketBeat
Crocs Inc (CROX) Stock Price Up 3.61% on Jun 10 - GuruFocus
Crocs, Inc. (CROX): A Bull Case Theory - Insider Monkey
Crocs, Inc. (NASDAQ:CROX) Shares Sold by Rhumbline Advisers - MarketBeat
Merit Financial Group LLC Raises Stock Holdings in Crocs, Inc. (NASDAQ:CROX) - MarketBeat
Crocs, Inc. (NASDAQ:CROX) Receives $139.79 Average Price Target from Analysts - MarketBeat
Crocs, Inc. (NASDAQ:CROX) Shares Acquired by Wealth Enhancement Advisory Services LLC - MarketBeat
Brokerages Set Crocs, Inc. (NASDAQ:CROX) PT at $139.79 - Defense World
30,903 Shares in Crocs, Inc. (NASDAQ:CROX) Bought by Universal Beteiligungs und Servicegesellschaft mbH - MarketBeat
Do Options Traders Know Something About Crocs Stock We Don't? - Nasdaq
Public Employees Retirement System of Ohio Cuts Stock Holdings in Crocs, Inc. (NASDAQ:CROX) - MarketBeat
Piper Sandler reiterates overweight rating on Crocs stock - Investing.com
Piper Sandler reiterates overweight rating on Crocs stock By Investing.com - Investing.com UK
Jefferies Financial Group Inc. Takes Position in Crocs, Inc. (NASDAQ:CROX) - MarketBeat
Crocs, Inc. (NASDAQ:CROX) Position Boosted by 180 Wealth Advisors LLC - MarketBeat
Investor Alert: Johnson Fistel Investigates Regeneron - GlobeNewswire
Investor Alert: Johnson Fistel Investigates Regeneron Pharmaceuticals, Integral Ad Science, Manhattan Associates, and Crocs on Behalf of Shareholders - GlobeNewswire Inc.
EXEC: Crocs, Inc. to Emphasize Inventory Controls to Ride Out Tariff Uncertainty - SGB Media
Crocs at Baird Conference: Strategic Growth Amid Challenges By Investing.com - Investing.com Nigeria
Crocs at Baird Conference: Strategic Growth Amid Challenges - Investing.com
Transcript : Crocs, Inc. Presents at Baird Global Consumer, Technology & Services Conference 2025, Jun-03-2025 08 - marketscreener.com
Crocs launches return service in Europe - FashionUnited
Crocs, Inc. (NASDAQ:CROX) Shares Sold by Wellington Management Group LLP - MarketBeat
Unpacking the Latest Options Trading Trends in Crocs - Nasdaq
Fairtree Asset Management Pty Ltd Makes New Investment in Crocs, Inc. (NASDAQ:CROX) - MarketBeat
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Increases Position in Crocs, Inc. (NASDAQ:CROX) - MarketBeat
Crocs stock news online - namibian.com.na
Deutsche Bank AG Boosts Stock Holdings in Crocs, Inc. (NASDAQ:CROX) - Defense World
Crocs, Inc. (NASDAQ:CROX) Shares Bought by ProShare Advisors LLC - Defense World
Brokers Suggest Investing in Crocs (CROX): Read This Before Placing a Bet - Yahoo Finance
Vident Advisory LLC Raises Position in Crocs, Inc. (NASDAQ:CROX) - MarketBeat
Crocs Boosts Terence Reilly To Chief Brand Officer 05/28/2025 - MediaPost
Nuveen Asset Management LLC Has $23.64 Million Position in Crocs, Inc. (NASDAQ:CROX) - MarketBeat
Crocs, Inc. to Present at Baird's 2025 Global Consumer, Technolo - GuruFocus
Finanzdaten der Crocs Inc-Aktie (CROX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Crocs Inc-Aktie (CROX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Bickley Ian | Director |
May 12 '25 |
Sale |
115.89 |
3,044 |
352,784 |
27,505 |
0.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):